Qingdao Vland Biotech INC. (SHA:603739)

China · Delayed Price · Currency is CNY

12.91

-0.19 (-1.45%)

Sep 2, 2026, 1:19 PM CST

-11.82% (1Y)

Market Cap	3.31B -10.5%
Revenue (ttm)	1.42B +4.4%
Net Income	81.65M +36.1%
EPS	0.32 +32.5%
Shares Out	253.03M
PE Ratio	41.14
Forward PE	37.43
Dividend	0.10 (0.80%)
Ex-Dividend Date	May 29, 2026

Volume	3,118,700
Open	12.97
Previous Close	13.10
Day's Range	12.82 - 13.09
52-Week Range	10.68 - 18.41
Beta	0.39
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SHA:603739

Qingdao Vland Biotech INC. engages in the research and development, production, and sale of enzyme preparations, microecological preparations, and animal health products in China and internationally. It offers feed, industrial, and food enzymes; and probiotics, including aquaculture premixes, health products, food probiotics, environmental microorganisms, and animal and plant probiotics. The company also offers animal vaccines and biological products, such as live and inactivated, and poultry and swine vaccines, as well as egg yolk antibodies; ... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2005

Employees 1,522

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 603739

Full Company Profile

Financial Performance

In 2025, SHA:603739's revenue was 1.37 billion, an increase of 3.43% compared to the previous year's 1.32 billion. Earnings were 69.81 million, an increase of 11.45%.

Financial Statements